441 related articles for article (PubMed ID: 16991082)
1. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
[TBL] [Abstract][Full Text] [Related]
2. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
6. Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis.
Barozzi P; Potenza L; Riva G; Vallerini D; Quadrelli C; Bosco R; Morselli M; Forghieri F; Volzone F; Rossi G; Ferri C; Bonini C; Ciceri F; Bordignon C; Whitby D; Schulz TF; Torelli G; Luppi M
Semin Arthritis Rheum; 2009 Dec; 39(3):170-5. PubMed ID: 18639317
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 8 cellular immune responses in homosexual men.
Strickler HD; Goedert JJ; Bethke FR; Trubey CM; O'Brien TR; Palefsky J; Whitman JE; Ablashi D; Zeichner S; Shearer GM
J Infect Dis; 1999 Nov; 180(5):1682-5. PubMed ID: 10515832
[TBL] [Abstract][Full Text] [Related]
9. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma.
Lebbé C; Agbalika F; de Crémoux P; Deplanche M; Rybojad M; Masgrau E; Morel P; Calvo F
Arch Dermatol; 1997 Jan; 133(1):25-30. PubMed ID: 9006369
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
11. Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.
Tedeschi R; Enbom M; Bidoli E; Linde A; De Paoli P; Dillner J
J Clin Microbiol; 2001 Dec; 39(12):4269-73. PubMed ID: 11724831
[TBL] [Abstract][Full Text] [Related]
12. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
[TBL] [Abstract][Full Text] [Related]
14. Correlation between enzyme-linked immunosorbent assay and immunofluorescence assay with lytic antigens for detection of antibodies to human herpesvirus 8.
Topino S; Vincenzi L; Mezzaroma I; Nicastri E; Andreoni M; Sirianni MC
Clin Diagn Lab Immunol; 2001 Jan; 8(1):203-5. PubMed ID: 11139222
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
16. Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma.
Barozzi P; Bonini C; Potenza L; Masetti M; Cappelli G; Gruarin P; Whitby D; Gerunda GE; Mondino A; Riva G; Vallerini D; Quadrelli C; Bosco R; Ciceri F; Bordignon C; Schulz TF; Torelli G; Luppi M
Transplantation; 2008 Sep; 86(5):738-44. PubMed ID: 18791457
[TBL] [Abstract][Full Text] [Related]
17. Impact of Kaposi sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins.
Woodberry T; Suscovich TJ; Henry LM; Martin JN; Dollard S; O'Connor PG; Davis JK; Osmond D; Lee TH; Kedes DH; Khatri A; Lee J; Walker BD; Scadden DT; Brander C
J Infect Dis; 2005 Aug; 192(4):622-9. PubMed ID: 16028131
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
Ariyoshi K; Schim van der Loeff M; Cook P; Whitby D; Corrah T; Jaffar S; Cham F; Sabally S; O'Donovan D; Weiss RA; Schulz TF; Whittle H
J Hum Virol; 1998; 1(3):193-9. PubMed ID: 10195242
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
20. Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association.
Mwakigonja AR; Pak F; Pyakurel P; Mosha IJ; Urassa WK; Kaaya EE; Biberfeld P
Oncol Rep; 2007 Jun; 17(6):1291-9. PubMed ID: 17487381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
